Philip A. van Damme
Fondatore presso Stichting Sanammad
Profilo
Philip A.
van Damme is the founder who has founded Stichting Sanammad in 2009 and Sanammad Pharmaceuticals BV in 2014, where he holds the title of President & Director.
He was also a former Director, Chief Scientific & Medical Officer at AXIM Biotechnologies, Inc. from 2014 to 2020 and a former Director at CanChew Biotechnologies LLC from 2012 to 2013.
Dr. van Damme earned a doctorate degree from the University of Utrecht in 1983.
Posizioni attive di Philip A. van Damme
| Società | Posizione | Inizio |
|---|---|---|
| Stichting Sanammad | Fondatore | 01/01/2009 |
| Sanammad Pharmaceuticals BV | Fondatore | 01/01/2014 |
Precedenti posizioni note di Philip A. van Damme
| Società | Posizione | Fine |
|---|---|---|
| AXIM BIOTECHNOLOGIES, INC. | Direttore Tecnico/Scientifico/R&S | 06/05/2020 |
CanChew Biotechnologies LLC
 CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Philip A. van Damme
| University of Utrecht | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AXIM BIOTECHNOLOGIES, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
CanChew Biotechnologies LLC
CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Health Technology |
| Stichting Sanammad | Miscellaneous |
| Sanammad Pharmaceuticals BV |
- Borsa valori
- Insiders
- Philip A. van Damme
